Fresh Rounds

Commense Bio, Inc. funding

Commense Bio, Inc., a biotechnology company based in Boulder, CO, filed a Form D with the SEC on June 12, 2026 and reported $2.5M raised of a $2.7M offering.

Amount raised$2.5M
Offering size$2.7M
Filed with the SECJune 12, 2026
First saleJanuary 18, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationBoulder, CO
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far31
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Colorado